Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-8777 in adults with ADHD
NCT00610441Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Org 26576 in attention deficit hyperactivity disorder (ADHD), sponsored by Merck & Co.. Started Apr 2008; status: completed.
02
Drugs
Org 26576
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00610441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00610441.